Mitochondria and Metabolism Center, Department of Anesthesiology and Pain Medicine, University of Washington, Republican Street 850, 98109 Seattle, WA, USA.
Mitochondria and Metabolism Center, Department of Anesthesiology and Pain Medicine, University of Washington, Republican Street 850, 98109 Seattle, WA, USA; Heart and Muscle Metabolism Laboratory, Health and Exercise Physiology, Ursinus College, Collegeville, PA 19426, USA.
J Mol Cell Cardiol. 2021 Sep;158:1-10. doi: 10.1016/j.yjmcc.2021.05.004. Epub 2021 May 12.
Reduced fatty acid oxidation (FAO) is a hallmark of metabolic remodeling in heart failure. Enhancing mitochondrial long-chain fatty acid uptake by Acetyl-CoA carboxylase 2 (ACC2) deletion increases FAO and prevents cardiac dysfunction during chronic stresses, but therapeutic efficacy of this approach has not been determined.
Male and female ACC2 f/f-MCM (ACC2KO) and their respective littermate controls were subjected to chronic pressure overload by TAC surgery. Tamoxifen injection 3 weeks after TAC induced ACC2 deletion and increased FAO in ACC2KO mice with pathological hypertrophy.
ACC2 deletion in mice with pre-existing cardiac pathology promoted FAO in female and male hearts, but improved cardiac function only in female mice. In males, pressure overload caused a downregulation in the mitochondrial oxidative function. Stimulating FAO by ACC2 deletion caused unproductive acyl-carnitine accumulation, which failed to improve cardiac energetics. In contrast, mitochondrial oxidative capacity was sustained in female pressure overloaded hearts and ACC2 deletion improved myocardial energetics. Mechanistically, we revealed a sex-dependent regulation of PPARα signaling pathway in heart failure, which accounted for the differential response to ACC2 deletion.
Metabolic remodeling in the failing heart is sex-dependent which could determine the response to metabolic intervention. The findings suggest that both mitochondrial oxidative capacity and substrate preference should be considered for metabolic therapy of heart failure.
脂肪酸氧化(FAO)减少是心力衰竭代谢重构的标志。通过乙酰辅酶 A 羧化酶 2(ACC2)缺失增加长链脂肪酸摄取来增强线粒体 FAO 可预防慢性应激期间的心脏功能障碍,但该方法的治疗效果尚未确定。
雄性和雌性 ACC2 f/f-MCM(ACC2KO)及其相应的同窝对照小鼠通过 TAC 手术接受慢性压力超负荷。TAC 后 3 周注射他莫昔芬诱导 ACC2 缺失并增加 ACC2KO 小鼠病理性肥大中的 FAO。
在存在心脏病理学的小鼠中,ACC2 的缺失促进了雌雄心脏中的 FAO,但仅在雌性小鼠中改善了心脏功能。在雄性中,压力超负荷导致线粒体氧化功能下调。通过 ACC2 缺失刺激 FAO 会导致无生产力的酰基辅酶 A 积累,无法改善心脏能量学。相比之下,在雌性压力超负荷心脏中维持了线粒体氧化能力,并且 ACC2 缺失改善了心肌能量学。从机制上讲,我们揭示了心力衰竭中 PPARα 信号通路的性别依赖性调节,这解释了对 ACC2 缺失的不同反应。
衰竭心脏中的代谢重构是依赖于性别的,这可能决定了对代谢干预的反应。研究结果表明,对于心力衰竭的代谢治疗,应同时考虑线粒体氧化能力和底物偏好。